 |
|
Global burden of primary liver cancer and its association with underlying aetiologies, sociodemographic status, and sex differences from 1990–2019: A DALY-based analysis of the Global Burden of Disease 2019 study
Sungchul Choi, Beom Kyung Kim, Dong Keon Yon, Seung Won Lee, Han Gyeol Lee, Ho Hyeok Chang, Seoyeon Park, Ai Koyanagi, Louis Jacob, Elena Dragioti, Joaquim Radua, Jae Il Shin, Seung Up Kim, Lee Smith
Clin Mol Hepatol. 2023;29(2):433-452. Published online 2023 Jan 4 DOI: https://doi.org/10.3350/cmh.2022.0316
|
|
Citations to this article as recorded by
 The Epidemiology of Hepatitis B Virus Infection in Korea: 15-Year Analysis
Log Young Kim, Jeong-Ju Yoo, Young Chang, Hoongil Jo, Young Youn Cho, Sangheun Lee, Dong Hyeon Lee, Jae Young Jang
Journal of Korean Medical Science.2024;[Epub] CrossRef Investigating Alternative Treatment Options Unfeasible for Local Ablation Therapy in Patients with Small Solitary Hepatocellular Carcinomas
Chang Hun Lee, In Hee Kim
Gut and Liver.2024; 18(1): 5. CrossRef Hepatitis B Virus Elimination Strategies
Mimi Xu, Norah A. Terrault
Current Hepatology Reports.2024;[Epub] CrossRef Withdrawn: Acute Rejection was Observed in a Combination Therapy of CTLA-4 and PD-1 Inhibitors Before Liver Transplantation: A Case Report and Literature Review
Pengpeng Zhang, Tianyin Wang, Hong Liu, Xingguo She, Ke Chen, Yujun Zhao, Yingzi Ming
iLIVER.2023;[Epub] CrossRef The latest global burden of liver cancer: A past and present threat
Joo Hyun Oh, Dae Won Jun
Clinical and Molecular Hepatology.2023; 29(2): 355. CrossRef The current trends in the health burden of primary liver cancer across the globe
Peter Konyn, Aijaz Ahmed, Donghee Kim
Clinical and Molecular Hepatology.2023; 29(2): 358. CrossRef Global trajectories of liver cancer burden from 1990 to 2019 and projection to 2035
Fan Yang, Dianqin Sun, Changfa Xia, He Li, Maomao Cao, Xinxin Yan, Siyi He, Shaoli Zhang, Wanqing Chen
Chinese Medical Journal.2023; 136(12): 1413. CrossRef Evaluation of the Safety and Efficacy of Conventional Transarterial Chemoembolization (cTACE) and Drug-Eluting Bead (DEB)-TACE in the Management of Unresectable Hepatocellular Carcinoma: A Systematic Review
Javaria Ayyub, Karan Nareshbhai Dabhi, Namra V Gohil, Nida Tanveer, Sally Hussein, Shravya Pingili, Vijaya Krishna Makkena, Arturo P Jaramillo, Babatope L Awosusi, Tuheen Sankar Nath
Cureus.2023;[Epub] CrossRef Core indicators related to the elimination of hepatitis B and C virus infection in South Korea: A nationwide study
Chang Hun Lee, Gwang Hyeon Choi, Hwa Young Choi, Sojung Han, Eun Sun Jang, Young Eun Chon, Young Chang, Kyung-Ah Kim, Do Young Kim, Hyung Joon Yim, Hye-Lin Kim, Sook-Hyang Jeong, In Hee Kim
Clinical and Molecular Hepatology.2023; 29(3): 779. CrossRef Risk factors associated with late hepatocellular carcinoma detection in patients undergoing regular surveillance
Sangmi Jang, Young-Joo Jin, Jin-Woo Lee, Dam Kwon, Jung Hwan Yu
Medicine.2023; 102(32): e34637. CrossRef Global, regional, and national burden of liver cancer due to non-alcoholic steatohepatitis, 1990–2019: a decomposition and age–period–cohort analysis
Chunlong Liu, Shijie Zhu, Jian Zhang, Panpan Wu, Xuan Wang, Sen Du, Enzhao Wang, Yunkang Kang, Kun Song, Jiangtao Yu
Journal of Gastroenterology.2023; 58(12): 1222. CrossRef Nonalcoholic Fatty Liver Disease as a Systemic Disease and the Need for Multidisciplinary Care
Masato Yoneda, Takashi Kobayashi, Michihiro Iwaki, Asako Nogami, Satoru Saito, Atsushi Nakajima
Gut and Liver.2023; 17(6): 843. CrossRef Potential Anti-Cancer Effects of Extra Virgin Olive Oil and Its Phenolic Extracts on Hepatocellular Carcinoma Cells
Gül KAHRAMAN, Mücahit Taha ÖZKAYA, Özlem YILDIRIM
International Journal of Nature and Life Sciences.2023; 7(2): 112. CrossRef
|